All Type of News
“Dentists’ botox procedures are unlicensed medical actionss”
While illegality of dentists’ botox procedures will be finally judged by the Supreme Court, the Korean Medical Association(KMA) expressed an opinion that the judgments in the 1st and 2nd trials which found guilty on d...
Multinational pharmaceuticals earn KRW 25 out of products worth KRW 1,000
Multinational pharmaceutical companies were analyzed to make only KRW 25 out of selling a product worth of KRW 1,000 in the Korean market.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audi...
“There is a low chance for olmesartan therapies to cause trouble in Korea”
The Korean Society of Hypertension turned in “Reply to the French Olmesartan Issue” to the Ministry of Food and Drug Safety(MFDS) on April 19.
The reply is a follow-up of the MFDS’s request for the “Opinions and Dat...
Roche Korea appoints Matt Sause as new CEORoche Korea announced the appointment of Matt Sause as a new CEO.
CEO Matt Sause will take charge in every department of Roche Korea, a part of Roche Group.
After joining Roc...
|
J&J kept Berna Biotech reborn as ‘Janssen Vaccine’
Berna Biotech was reborn as ‘Janssen Vaccine.’
According to the industry concerned on the 20th, a vaccine manufacturer Berna Biotech changed its name to Janssen Vaccine, launched as a subsidiary of a multinational p...
Re-categorization of thyroid cancer in US triggers ‘excessive diagnosis’ in Korea
It seems the U.S. movement of changing the name of thyroid cancer – follicular thyroid cancer must be called as tumor, not cancer – will again trigger the Korean ‘thyroid cancer’s excessive diagnosis’ issue.
Univers...
‘Cruel April’ in pharmaceutical industry
The pharmaceutical industry has been messy this April because rebate investigation, FTC’s(Fair Trade Commission) investigation, and tax investigation either was conducted or being conducted now.
First, the pharmaceut...
‘Pfizer Pharmaceuticals Korea’ to spend most advertising expenses in pharmaceutical industry
A company which spend the most advertising expenses last year among other multinational pharmaceutical companies branched in Korea was Pfizer Pharmaceuticals Korea with more than KRW 50 billion. The amount was more th...
Industry pays attention to AZ’s Symbicort Rapihaler
AstraZeneca Korea’s ‘Symbicort Rapihaler’ which strengthened its inhaler portfolio has attracted interests of the industry.
AstraZeneca Korea introduced ‘Symbicort Rapihaler’ through a press conference on the 18th, ...
Court prohibited manufacturing and sales of Glivec generics for GIST
The court accepted the Glivec’s use patent of gastrointestinal stromal tumor(GIST), and ordered to prohibit sales and manufacturing of its generics for the indication.
The 12th Civil Department, Seoul Central Distri...
